Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 多克隆抗體
  4. FOXD3 Antibody

FOXD3 Antibody

  • 中文名稱：
    FOXD3兔多克隆抗體
  • 貨號(hào)：
    CSB-PA173245
  • 規(guī)格：
    ￥1100
  • 圖片：
    • Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Hela cells, Primary antibody: CSB-PA173245(FOXD3 Antibody) at dilution 1/450, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
  • 其他：

產(chǎn)品詳情

  • Uniprot No.：
  • 基因名：
  • 別名：
    AIS1 antibody; forkhead box D3 antibody; Forkhead box protein D3 antibody; foxd3 antibody; FOXD3_HUMAN antibody; Genesis antibody; HFH2 antibody; HNF3/FH transcription factor genesis antibody; VAMAS2 antibody
  • 宿主：
    Rabbit
  • 反應(yīng)種屬：
    Human,Mouse
  • 免疫原：
    Synthetic peptide of Human FOXD3
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 抗體亞型：
    IgG
  • 純化方式：
    Antigen affinity purification
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用范圍：
    ELISA,WB
  • 推薦稀釋比：
    Application Recommended Dilution
    ELISA 1:1000-1:5000
    WB 1:500-1:2000
  • Protocols：
  • 儲(chǔ)存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能：
    Binds to the consensus sequence 5'-A[AT]T[AG]TTTGTTT-3' and acts as a transcriptional repressor. Also acts as a transcriptional activator. Promotes development of neural crest cells from neural tube progenitors. Restricts neural progenitor cells to the neural crest lineage while suppressing interneuron differentiation. Required for maintenance of pluripotent cells in the pre-implantation and peri-implantation stages of embryogenesis.
  • 基因功能參考文獻(xiàn)：
    1. FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. PMID: 30076902
    2. On the basis of these data, FOXD3 is a potent repressor of DCLK1-S expression in normal cells; loss of FOXD3 in hCCCs/hCRCs allows upregulation of DCLK1-S, imparting a potent invasive potential to the cells PMID: 28851816
    3. FOXD3 knockdown resulted in enhanced ATC proliferation, invasion and migration and diminished cellular apoptosis. Further, we showed that FOXD3 regulated expression of E-cadherin by modulating MAPK/EKR signaling pathway that promotes EMT and metastasis during thyroid carcinogenesis. PMID: 28430585
    4. Results show that FOXD3 expression was reduced in colon cancer cells. Its knockdown dramatically increased the proliferation of tumor cells, enhanced cell invasiveness and inhibited cell apoptosis. The study indicates that FOXD3 may play a protective role in human colon formation by regulating EGFR/Ras/Raf/MEK/ERK signal pathway. PMID: 27926503
    5. FOXO4 and FOXD3 were shown independently predictive of overall survival in gastric cancer PMID: 27027443
    6. FOXD3/miR-214/MED19 axis is important for the regulation of growth, invasion and metastasis of colorectal cancer PMID: 27811858
    7. total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers PMID: 28349825
    8. Results showed that silencing FoxD3 in lung cancer cell lines stimulated cell growth and inhibited cell apoptosis. PMID: 25894280
    9. FOXD3 is sufficient but not necessary to drive PAX3 expression in melanoma cells. PMID: 26252164
    10. The present study finds that the aspirin-FOXD3-OLA1P2-STAT3 axis exhibits exciting anticancer effects and provides new insights into the chemopreventive mechanisms underlying aspirin use PMID: 26898989
    11. FOXD3 might serve as an independent prognostic biomarker and a potential therapeutic target for high-grade gliomas, which warrant further investigation. PMID: 26011451
    12. Down-regulation of FOXD3 is associated with metastasis in hepatocellular carcinoma. PMID: 26112097
    13. Data show that transcription factors PAX3 and FOXD3-mediated melanoma cell migration is dependent on promoting the expression of chemokine receptor CXCR4. PMID: 26205821
    14. In addition to a possible association of rs78645479 in FoxD3 with vitiligo, our data on the association of this FoxD3 variant with thyroid autoantibodies suggest a potential involvement of FoxD3 in thyroid immunoregulation. PMID: 26267147
    15. FOXD3 overexpression significantly inhibits cell growth and results in G1 cell cycle arrest in NSCLC A549 and H1299 cells. PMID: 26341266
    16. FOXD3 and TWIST1 define distinct subgroups of cells within a heterogeneous tumor. PMID: 25061102
    17. Findings indicate that miR-137 is a valuable biomarker for hepatocellular carcinoma (HCC) prognosis and the forkhead box D3 (FoxD3)/miR-137/AKT2 regulatory network plays an important role in HCC progression. PMID: 24970808
    18. Results suggest an inverse relationship between FoxD3 expression and tumor metastasis in invasive ductal carcinomas of the breast. PMID: 24551288
    19. Results indicate that FOXD3 exhibits tumor suppressive activity that affects the growth, aggressiveness and angiogenesis of NB through transcriptional regulation of NDRG1. PMID: 24269992
    20. Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy. PMID: 24632201
    21. Foxd3 is both sufficient and necessary for regulating the balance between melanocyte and Schwann cell development. In addition, Foxd3 is also sufficient to regulate the switch between neuronal and glial fates in sensory ganglia. PMID: 23858437
    22. upregulation of ERBB3 is involved in melanoma adapting to RAF/MEK inhibitors through FOXD3 PMID: 23543055
    23. Methylation profile analyses identified the promoter of FOXD3 as the only genomic region with increased methylation in mice and humans during progression of Helicobacter pylori-associated gastric tumors. PMID: 23058321
    24. A balance of FOXD3 activity is required to maintain pluripotency and paraxial mesoderm fates. PMID: 22887036
    25. Six nonsynonymous FOXD3 variants were identified in human ocular disease. PMID: 22815627
    26. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells PMID: 21478267
    27. Studies show FOXD3 is suppressed by B-RAF, uncover a novel role and mechanism for FOXD3 as a negative cell cycle regulator, and have implications for the repression of melanocytic lineage cells. PMID: 20332228
    28. candidate for vitilago susceptibility and autosomal dominant with promoter variation PMID: 16098053
    29. HIV-1 induces OTK18 expression through a YIN-YANG-1 mediated manner in human macrophages, although its gene expression is suppressed by FoxD3 upregulation PMID: 19034670

    顯示更多

    收起更多

  • 相關(guān)疾病：
    Autoimmune disease 1 (AIS1)
  • 亞細(xì)胞定位：
    Nucleus.
  • 組織特異性：
    Expressed in chronic myeloid leukemia, Jurkat T-cell leukemia and teratocarcinoma cell lines, but not in any other cell lines or normal tissues examined.
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 3804

    OMIM: 607836

    KEGG: hsa:27022

    STRING: 9606.ENSP00000360157

    UniGene: Hs.546573